NYMX

Nymox Pharmaceutical Corp
NYMX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NYMX was delisted on the 6th of July, 2023.

Back to rankings

39 hedge funds and large institutions have $2.15M invested in Nymox Pharmaceutical Corp in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less call options, than puts

Call options by funds: $ | Put options by funds: $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

57% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 7

Holders
39
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$35K
Puts
$37K
Net Calls
Net Calls Change

Top Buyers

1
+$137K
2
+$96K
3
+$94K
4
CH
CVI Holdings
Delaware
+$58K
5
WP
WMS Partners
Maryland
+$53K

Top Sellers

1
-$132K
2
-$44.1K
3
-$33K
4
Millennium Management
Millennium Management
New York
-$28K
5
FTDI
First Trust Direct Indexing
Massachusetts
-$15K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$15K
27
$14K
28
$13K
29
$13K
30
$12K
31
$12K
32
$10K
33
$3K
34
$2.14K
35
$2K
36
$1K
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
45
–
46
–
1
2